PERISCOPE CAPITAL INC. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 67 filers reported holding BIOPLUS ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$2,709,975
+1.8%
250,0000.0%0.31%
+47.8%
Q2 2023$2,662,500
-46.8%
250,000
-47.8%
0.21%
-10.4%
Q1 2023$5,002,274
+131.7%
479,145
+127.7%
0.23%
+148.4%
Q4 2022$2,158,909
+47.9%
210,420
+44.6%
0.09%
+121.4%
Q3 2022$1,460,000
-41.6%
145,500
-41.8%
0.04%
-37.3%
Q2 2022$2,502,000
+1.4%
249,8000.0%0.07%
+6.3%
Q1 2022$2,468,000249,8000.06%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders